Movain Tablet

About Movain 10 mg Tablet

Movain 10 mg tablet contains metoclopramide hydrochloride, a prescription anti-emetic medicine. It is used for certain stomach and bowel problems when other treatment has not worked, and for some people with diabetes-related stomach emptying problems.

There are 19 brands of Metoclopramide Hydrochloride listed in Bangladesh. The lowest listed price is Motilon 10 mg Tablet at ৳ 0.34 per unit.

What is Movain 10 mg Tablet?

Movain is a tablet made by G. A. Company Ltd. containing 10 mg of metoclopramide hydrochloride. It belongs to a group of medicines called anti-emetics. In tablet form, metoclopramide is used for adults with documented gastroesophageal reflux symptoms who have not responded to usual treatment, for a limited course. It is also used for adults with acute and recurrent diabetic gastroparesis. Metoclopramide works on dopamine and serotonin receptors in the brain and on the upper gut, helping the stomach empty and increasing the tone of the lower esophageal sphincter. It is a prescription medicine, and the doctor decides whether it is suitable.

Uses of Movain

Movain 10 mg tablet is used in adults for two main situations. One is symptomatic, documented gastroesophageal reflux that has not improved with conventional therapy; in this case it is used for a limited treatment course decided by the doctor. The other is relief of symptoms in adults with acute and recurrent diabetic gastroparesis, a stomach-emptying problem linked to diabetes. It is not for everyone, and the doctor will assess your symptoms and history before prescribing it.

How to use Movain

Take Movain exactly as your doctor tells you. The doctor decides the dose, how often to take it and how long the course should last, so follow the instructions on your prescription and do not change them yourself. Swallow the tablet with water. If you forget a dose or are unsure about anything, ask your doctor or pharmacist rather than adjusting the medicine on your own. Do not stop or continue the course without medical advice.

Side effects of Movain

The most common side effects reported with metoclopramide are a changed taste, headache and tiredness. Some people may have other reactions. Tell your doctor if any side effect bothers you or does not go away. Seek medical help straight away if you notice unusual muscle movements, stiffness, tremor, restlessness, fever, confusion, or mood changes such as low mood or thoughts of harming yourself. Your doctor can advise what to do.

Safety and precautions

Movain is not suitable for everyone. Tell your doctor before using it if you have had tardive dyskinesia or a dystonic reaction to metoclopramide, epilepsy, pheochromocytoma or similar tumours, bleeding, blockage or perforation in the gut, Parkinson's disease, or depression. It should not be used with other medicines that can cause similar movement problems or neuroleptic malignant syndrome. Pregnancy and breastfeeding: metoclopramide should be used in pregnancy only if clearly needed, and caution is needed during breastfeeding because it passes into human milk. Ask your doctor first if you are pregnant, planning pregnancy or breastfeeding.

Frequently asked questions

What is Movain 10 mg tablet used for and what kind of medicine is it?

Movain is an anti-emetic tablet containing metoclopramide hydrochloride 10 mg. In tablet form it is used in adults for symptomatic, documented gastroesophageal reflux that has not responded to conventional therapy, and for symptoms of acute and recurrent diabetic gastroparesis. The doctor decides if it is right for you.

Is Movain safe to use during pregnancy or breastfeeding?

Metoclopramide should be used during pregnancy only if clearly needed, because there are no adequate well-controlled studies in pregnant women. It passes into human milk, so caution is needed while breastfeeding. Do not start or stop Movain without asking your doctor or pharmacist first.

What side effects should I watch for, and when should I call the doctor?

Common side effects include changed taste, headache and tiredness. Call your doctor promptly if you notice unusual muscle movements, stiffness, tremor, restlessness, fever, confusion, or changes in mood such as low mood or thoughts of self-harm, or if any side effect is severe or persistent.

Who should not take Movain without checking with a doctor first?

Tell your doctor if you have had tardive dyskinesia or a dystonic reaction to metoclopramide, epilepsy, pheochromocytoma or a similar tumour, gut bleeding, blockage or perforation, Parkinson's disease, or depression. Also mention all other medicines you take, because some should not be combined with metoclopramide.

Indications

Metoclopramide nasal spray: This is a dopamine-2 (D2) antagonist indicated for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.

Metoclopramide tablet:
  • This is indicated in the treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy.
  • ... Read more
Metoclopramide nasal spray: This is a dopamine-2 (D2) antagonist indicated for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.

Metoclopramide tablet:
  • This is indicated in the treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy.
  • Relief of symptoms in adults with acute and recurrent diabetic gastroparesis.
Metoclopramide Injection:
  • Diabetic Gastroparesis (Diabetic Gastric Stasis): Metoclopramide Injection is indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis.
  • The Prevention of Nausea and Vomiting Associated with Emetogenic Cancer Chemotherapy: Metoclopramide Injection is indicated for the prophylaxis of vomiting associated with emetogenic cancer chemotherapy.
  • The Prevention of Postoperative Nausea and Vomiting: Metoclopramide Injection is indicated for the prophylaxis of postoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable.
  • Small Bowel Intubation: Metoclopramide Injection may be used to facilitate small bowel intubation in adults and pediatric patients in whom the tube does not pass the pylorus with conventional maneuvers.
  • Radiological Examination: Metoclopramide Injection may be used to stimulate gastric emptying and intestinal transit of barium in cases where delayed emptying interferes with radiological examination of the stomach and/or small intestine.

Pharmacology

Metoclopramide blocks dopamine receptors and in higher doses, it also blocks serotonin receptors in chemoreceptor trigger zone of the CNS. It enhances the response to acetylcholine of tissue in upper GI tract causing enhanced motility and accelerated gastric emptying w/o stimulating gastric, biliary, or pancreatic secretions. It also increases lower esophageal sphincter tone.

Dosage & Administration

Metoclopramide Spray:

Adults less than 65 years of age: The recommended dosage is 1 spray (15 mg) in one nostril, 30 minutes before each meal and at bedtime (maximum of 4 sprays daily) for 2 to 8 weeks, depending on symptomatic response.

Adults 65 years of age and older: Metoclopramide is not recommended in geriatric patients as initial therapy. Geriatric patients receiving an alternative metoclopramide product at a stable dosage of 10 mg four times daily can be switched to Metoclopramide 1 spray (15 mg) in one nostril, 30 minutes before each meal and at bedtime (maximum four times daily) for 2 to 8 weeks, depending on symptomatic response.

Metoclopramide tablet:

Gastroesophageal Reflux: Administer Metoclopramide continuously or intermittently:
  • Continuous: Administer 10 to 15 mg, 30 minutes before each meal and at bedtime (maximum of 60 mg per day) for 4 to 12 weeks.
  • Intermittent: Single doses up to 20 mg prior to provoking situation.
Acute and Recurrent Diabetic Gastroparesis: Administer 10 mg, 30 minutes before each meal and at bedtime (maximum of 40 mg per day) for 2 to 8 weeks.

Metoclopramide injection:

For the Relief of Symptoms Associated with Diabetic Gastroparesis (Diabetic Gastric Stasis): If only the earliest manifestations of diabetic gastric stasis are present, oral administration of metoclopramide may be initiated. However, if severe symptoms are present, therapy should begin with Metoclopramide Injection (IM or IV). Doses of 10 mg may be administered slowly by the intravenous route over a 1- to 2-minute period. Administration of Metoclopramide Injection (metoclopramide injection, USP) up to 10 days may be required before symptoms subside, at which time oral administration of metoclopramide may be instituted. The physician should make a thorough assessment of the risks and benefits prior to prescribing further metoclopramide treatment.

For the Prevention of Nausea and Vomiting Associated with Emetogenic Cancer Chemotherapy: Intravenous infusions should be made slowly over a period of not less than 15 minutes, 30 minutes before beginning cancer chemotherapy and repeated every 2 hours for two doses, then every 3 hours for three doses. The initial two doses should be 2 mg/kg if highly emetogenic drugs such as cisplatin or dacarbazine are used alone or in combination. For less emetogenic regimens, 1 mg/kg per dose may be adequate.

For the Prevention of Postoperative Nausea and Vomiting: Metoclopramide Injection should be given intramuscularly near the end of surgery. The usual adult dose is 10 mg; however, doses of 20 mg may be used.

Contraindications

Metoclopramide is contraindicated:
  • In patients with a history of tardive dyskinesia (TD) or a dystonic reaction to metoclopramide.
  • When stimulation of gastrointestinal motility might be dangerous (e.g., in the presence of gastrointestinal hemorrhage, mechanical obstruction, or perforation).
  • In patients with pheochromocytoma or other catecholamine-releasing paragangliomas. Reglan may cause a hypertensive/pheochromocytoma crisis, probably due to release of catecholamines from the tumor.
  • In patients with epilepsy. Reglan may increase the frequency and severity of seizures.
  • In patients with hypersensitivity to metoclopramide. Reactions have included laryngeal and glossal angioedema and bronchospasm.

Side Effects

Most common adverse reactions (≥5%) are: dysgeusia, headache, and fatigue.

Pregnancy & Lactation

Pregnancy Category B. Reproduction studies performed in rats, mice and rabbits by the IM, IV, subcutaneous (SC), and oral routes at maximum levels ranging from 12 to 250 times the human dose have demonstrated no impairment of fertility or significant harm to the fetus due to metoclopramide. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

Nursing Mothers: Metoclopramide is excreted in human milk. Caution should be exercised when metoclopramide is administered to a nursing mother.

Precautions & Warnings

Tardive Dyskinesia (TD), Other Extrapyramidal Symptoms (EPS), and Neuroleptic Malignant Syndrome (NMS): Avoid concomitant use of other drugs known to cause TD/EPS/NMS and avoid use in patients with Parkinson’s Disease. If symptoms occur, discontinue Reglan and seek immediate medical attention.  

Depression and suicidal ideation/suicide: Avoid use.

Storage Conditions

Store between 20-25°C. Protect from light.

Alternative brands of Metoclopramide Hydrochloride

Other brands with the same generic name, cheapest first.

See all 19 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.